18 and older, any sex, with Migraine. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Headache Days as Self-reported by ParticipantsPrimary· 7 days after discharge from emergency department
At the seven day follow-up, participants will be asked by phone how many days they experienced headaches since being discharged.
Group
Value
95% CI
Control
3.0
2.5 – 3.5
Experimental
3.3
2.8 – 3.9
Number of Participants With Sustained Headache FreedomSecondary· 7 days after discharge from emergency department
Sustained headache freedom is defined as achieving a headache intensity = none within two hours of treatment and maintaining this level, without requiring additional headache medication, for 7 days following discharge from the Emergency Department. Participants will be asked by phone how number of days they experienced headaches during the week after discharge from the emergency department. Reported values are participants who experienced no headaches at all during the 7 days immediately following discharge.
Group
Value
95% CI
Control
10
Experimental
6
Medication Preference as Assessed by Self-reportSecondary· 7 days after discharge from emergency department
Participants will be asked, by phone, if they would want the same medication during a subsequent visit to the emergency department. Reported values indicate participants who responded "yes".
Group
Value
95% CI
Control
76
Experimental
75
Adverse events — posted to ClinicalTrials.gov
Time frame: 1 week.
Reporting threshold: 5%.
Adverse-event reports describe events observed during the trial — not all are caused by the drug.
This is an emergency department based randomized trial in which we compare two different treatment for migraine headache. The goal is to decrease the number of headache days during the week after ED discharge.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT05533281 — Efficacy of Three Antiemetics in Preventing Nausea and Vomiting
· Phase 4
· completed
NCT04252521 — Intravenous Metoclopramide Versus Dexketoprofen Trometamol Versus Metoclopramide+ Dexketoprofen Trometamol in Migraine
· NA
· completed
NCT02913469 — Effects of Morphine on Loading-dose Ticagrelor in Patients With ST-segment Elevation Myocardial Infarction
· Phase 4
· unknown
Other recruiting trials for Migraine
Currently open trials in the same condition.
NCT07419607 — MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducat
· NA
· recruiting
NCT07487701 — Migraine Prevention With the Remote Electrical Neuromodulation (REN) Wearable: A Real-world Evidence Study
· NA
· active not recruiting
NCT07343427 — Impact of GON PRF on Central Sensitization in Migraine Patients
· NA
· active not recruiting
NCT07336056 — Nerivio Efficacy Under High-Frequency Use
· Phase 4
· active not recruiting
NCT07385755 — Desvenlafaxine for Preventive Treatment of Frequent Migraines
· NA
· active not recruiting
Other Montefiore Medical Center trials
Trials by the same sponsor.
NCT07224061 — Promoting Asthma Management Guidelines With Technology-Based Intervention and Care Coordination in Clinics and Schools
· NA
· not yet recruiting
NCT06775886 — Effect of Personalized Accelerated Pacing in Symptomatic Patients With Non-Obstructive Hypertrophic Cardiomyopathy
· NA
· terminated
NCT06919094 — A Virtual Life Story Club Intervention to Improve Loneliness and Apathy in Community-Dwelling Older Adults
· NA
· recruiting
NCT07076069 — The Effect of Multimodal Pain Regimen on Use of Narcotics After Rotator Cuff Tear Repair
· Phase 4
· recruiting
NCT07037940 — Physician Response Evaluation With Contextual Insights vs. Standard Engines - Artificial Intelligence RAG vs LLM Clinica
· NA
· completed
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Montefiore Medical Center
Last refreshed: 8 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02847494.